Halozyme Therapeutics, Inc.
HALO
$63.65
-$1.48-2.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -79.65% | 28.05% | -26.71% | 25.47% | -10.54% |
| Total Receivables | 27.52% | 9.39% | 3.85% | -1.24% | 7.95% |
| Inventory | -5.02% | 2.36% | 10.09% | 16.22% | 7.95% |
| Prepaid Expenses | -31.93% | 23.88% | 71.80% | 14.55% | -10.49% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -37.90% | 18.36% | -11.04% | 16.28% | -3.69% |
|
|
|||||
| Total Current Assets | -37.90% | 18.36% | -11.04% | 16.28% | -3.69% |
| Net Property, Plant & Equipment | 15.01% | -0.14% | -1.78% | -2.96% | 0.73% |
| Long-term Investments | 39.23% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 39.23% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 181.59% | -4.85% | -4.62% | -4.42% | -4.23% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.82% | -27.27% | 25.95% | -28.01% | 5.36% |
| Total Assets | 13.69% | 8.15% | -6.49% | 6.45% | -2.58% |
|
|
|||||
| Total Accounts Payable | 36.06% | -17.82% | -6.89% | 95.86% | -17.33% |
| Total Accrued Expenses | 30.34% | -3.81% | -11.29% | 1.13% | 33.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -98.41% | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -78.85% | 523.48% | -10.70% | 8.11% | 27.83% |
|
|
|||||
| Total Current Liabilities | -78.85% | 523.48% | -10.70% | 8.11% | 27.83% |
| Long-Term Debt | 167.80% | -46.98% | 0.11% | 0.11% | 0.11% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -17.11% | -3.00% | -1.43% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 157.14% | 6.39% | 80.42% | -50.61% | 153.47% |
| Total Liabilities | 44.21% | -0.22% | 0.40% | 0.86% | 2.06% |
|
|
|||||
| Common Stock & APIC | -49.56% | 20,261.86% | -98.47% | 6,175.61% | -99.80% |
| Retained Earnings | -89.09% | 39.09% | -24.46% | 32.82% | -9.50% |
| Treasury Stock & Other | 18.72% | 21.64% | -732.20% | -189.14% | 155.18% |
| Total Common Equity | -90.31% | 51.44% | -31.00% | 32.56% | -19.63% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -90.31% | 51.44% | -31.00% | 32.56% | -19.63% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -90.31% | 51.44% | -31.00% | 32.56% | -19.63% |
|
|
|||||